Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPEMV.L Regulatory News (PEMV)

  • There is currently no data for PEMV

Quarterly Report

3 Mar 2015 16:17

RNS Number : 4401G
Pembroke VCT PLC
03 March 2015
 

3 March 2015

 

 

PEMBROKE VCT PLC

 

Quarterly Report

for the period from 1 October to 31 December 2014

 

Pembroke VCT plc (the "Company") presents its quarterly report for the period from 1 October to 31 December 2014.

 

· £2.9 million invested in the quarter to 31 December

· £15.8 million committed with £15.1 million invested to date

· New B Ordinary Share offer launched

 

This interim management statement contains information that covers the period up to the date of its publication.

 

Performance

 

The net asset value of the Company at 31 December 2014 was £17.8 million, broadly in line with the half-year report. In total, an additional £2.9 million was invested in the quarter in follow-on investments into the existing portfolio and into two new investments. Investments are held at fair value, with all but four still held at cost. No further revaluations have taken place since the half-yearly report was published in November 2014.

 

Investments made in the period

 

In the quarter ended 31 December 2014, the Company invested a total of £2.9 million comprising follow-on investments in seven portfolio companies amounting to £1.3 million and £1.6 million in two new investments.

 

Follow-on investments in the quarter ended 31 December 2014:

 

· Boom Cycle: Investment of £22,250 in new equity as part of the original committed capital

· Chucs Limited: Investment of £200,000 in new loan notes

· Bella Freud: Investment of £50,000 in new loan notes as part of the original committed capital

· Premium fast-food restaurant chain: Investment of £694,400 in loan notes as part of the original committed capital

· Penfield: Investment of £250,000 in new loan notes as part of the original committed capital

· Dilly & Wolf (formerly B Healthy Snacks): Investment of £50,000 in new loan notes as part of the original committed capital

· Bella Freud Perfume: Investment of £50,000 in new loan notes as part of the original committed capital

 

New investments in the quarter ended 31 December 2014:

 

· BLAZE: Commitment of £490,000, of which £100,000 was invested in new equity in the period (Media & Technology sector)

BLAZE, founded in 2012, designs, develops and manufactures hardware products which can predominantly be used in bicycles, using innovative technology and high quality materials. BLAZE's first product is the world's first laserlight, re-designing the classic bicycle light. The Company has invested £100,000 in the form of new ordinary equity, principally to fund ongoing working capital and the development of new products.

 

· Stillking Films: Commitment of $2,320,220 (£1,451,770), all of which was invested in new equity in the period (Media & Technology sector)

Stillking Films is a prolific producer of commercials, TV series, feature films and music videos. The company has created commercials for almost all Dow Jones and FTSE advertisers. They have co-produced a number of successful feature films including Casino Royale, Narnia, Mission Impossible 4 and The Bourne Identity and created music videos for artists including Beyoncé, Kanye West, Blur, Madonna and One Direction. The Company has invested $2,320,220 in the form of new equity, principally to grow the business through potential acquisition opportunities.

 

Investments made post-period end

 

Post the period end, the Company invested a total of £0.4m in follow on investments. These investments comprised:

 

· Plenish: Investment of £50,000 in new loan notes

· Chucs Bar & Grill: Investment of £130,000 in new loan notes

· Boom Cycle: Investment of £22,250 in new equity as part of the original committed amount

· Kat Maconie: Investment of £100,000 in new loan notes

· BLAZE: Investment of £100,000 in new equity as part of the original committed amount

 

New B Ordinary Share Offer

 

Following the success of its first offer of Ordinary Shares, the Company launched a new B Ordinary Share offer in October 2014. The B Ordinary Shares are a separate class of share, distinct from the existing Ordinary Shares, and with distinct rights to a separate pool of assets and liabilities.

 

The B Ordinary share offer has been positively received by the VCT market, with the Company receiving subscriptions and interest from existing shareholders and new investors alike. The Company has built a solid pipeline of new investments which are currently undergoing due diligence.

 

About the Company

 

Pembroke VCT plc (the "Company") is a generalist VCT focused on private equity style investments in the leisure and premium brands sectors. The Company seeks to invest in a diversified portfolio of small, principally unquoted companies, selecting those which Oakley Investment Managers LLP believes provide the opportunity for value appreciation.

 

The Company is not aware of any significant event or transaction which has occurred between 1 October 2014 and 27 February 2015 which has had a material effect on the financial position of the Company and has not been detailed above.

 

 

 

For further details about the Company please either visit the Company's website,

 

Pembroke VCT plc

www.pembrokevct.com,

 

or contact:

 

Oakley Investment Managers LLP (Manager)

+44 20 7766 6900

Peter Dubens / Andrew Wolfson

 

The City Partnership (UK) Limited (Company Secretary)

0131 243 7210

Doreen Nic

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPKNDDABKDQNK
Date   Source Headline
26th Aug 20201:35 pmRNSResult of Conversion of Shares
26th Aug 20207:30 amRNSSuspension of listing of ordinary shares
14th Aug 202011:46 amRNSResults of General and Ord Share class Meetings
4th Aug 20209:14 amRNSIntention to launch an offer for subscription
24th Jul 20203:39 pmRNSDividend Declaration
24th Jul 20203:38 pmRNSAnnual Financial Report
16th Jul 20202:57 pmRNSCirc re. Amendment to Articles
1st May 20209:29 amRNSTotal Voting Rights
14th Apr 202012:01 pmRNSIssue of Equity
6th Apr 20201:42 pmRNSIssue of Equity
3rd Apr 20205:13 pmRNSOffer for subscription closing date
1st Apr 20207:51 amRNSTotal Voting Rights
20th Mar 20204:59 pmRNSIssue of Equity
19th Mar 20201:58 pmRNSNet Asset Value(s)
2nd Mar 20204:20 pmRNSIssue of Equity
27th Feb 202011:28 amRNSOffer for subscription - over allotment facility
3rd Feb 202011:00 amRNSTotal Voting Rights
21st Jan 20203:35 pmRNSIssue of Equity
15th Jan 20205:13 pmRNSOffer for Subscription - over-allotment facility
18th Dec 20198:19 amRNSIssue of Equity
16th Dec 20194:15 pmRNSHolding(s) in Company
13th Dec 20193:21 pmRNSHalf-year Report
2nd Dec 20194:24 pmRNSTotal Voting Rights
8th Nov 20195:09 pmRNSIssue of Equity
31st Oct 20194:08 pmRNSIssue of Equity
16th Oct 20194:07 pmRNSOffer for subscription update
1st Oct 20194:22 pmRNSDirector/PDMR Shareholding
30th Sep 20195:33 pmRNSIssue of Equity
27th Sep 20198:16 amRNSResult of GM
27th Sep 20198:15 amRNSResult of AGM
23rd Sep 20194:36 pmRNSRelated party transaction
2nd Sep 20191:28 pmRNSPublication of Prospectus and Circular
1st Aug 201910:35 amRNSTotal Voting Rights
29th Jul 20195:17 pmRNSDividend Declaration
29th Jul 20195:15 pmRNSAnnual Financial Report
16th Jul 20199:39 amRNSIntention to launch an offer for subscription
5th Jul 20191:08 pmRNSIssue of Equity
4th Jun 20199:15 amRNSOffer for subscription closing date
3rd Jun 20191:19 pmRNSTotal Voting Rights
16th May 20194:39 pmRNSIssue of Equity
1st May 201912:18 pmRNSTotal Voting Rights
15th Apr 20192:40 pmRNSIssue of Equity - replacement
8th Apr 20194:08 pmRNSIssue of Equity
5th Apr 20197:59 amRNSOffer for subscription over allotment facility
2nd Apr 20193:04 pmRNSIssue of Equity
29th Mar 20194:20 pmRNSTransaction in Own Shares
1st Mar 20198:45 amRNSTotal Voting Rights
22nd Feb 201911:25 amRNSIssue of Equity
14th Dec 201811:42 amRNSHalf-year Report
13th Dec 20182:23 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.